ce-ivd Workflow Solution for illCE-IVD workflowCFTR MASTR Dx v1406SOMATIC MUTATIONS v1406

NEWS

New blood test identifies risk “Sudden Cardiac Death”

Antwerp, June 25 2014 – UAntwerp (University of Antwerp), UZA (Antwerp University Hospital), and Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests, together developed a blood test to determine the genetic risk of “Sudden Cardiac Death” (SCD). This test, called PED MASTR, is already in use at the center of medical genetics of UZA/UAntwerp and will be launched worldwide from September 2014.

Multiplicom launches two new diagnostic kits and aims for strong growth in the rapidly expanding molecular diagnostic market

Niel, June 4 2014 – Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), announces that it has achieved ISO 13485 accreditation, and is launching two new CE/IVD labeled DNA mutation detection kits for Cystic Fibrosis (CF) and Familial Mediterranean Fever (FMF), genetics diseases with a high carrier rate.

EVENTS

15 August Office closed due to public holiday

Assumption of Mary

30-3 Aug-Sept European Congress of Pathology

London, United Kingdom

4-7 Sept European Neurofibromatosis Meeting

Barcelona, Spain

22-24 Sept The British Society for Genetic Medicine (BSGM)

Liverpool, United Kingdom